ffeng	10.1200/JCO.2018.36.15_suppl.5012	<http://dx.doi.org/10.1200/jco.2018.36.15_suppl.5012>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.5012"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/mark-andrew-landers-1wh6jg4tnty1q"><j.3:name>Mark Andrew Landers</j.3:name><j.3:familyName>Landers</j.3:familyName><j.3:givenName>Mark Andrew</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/stephanie-daignault-newton-1wh6jg4tnty1q"><j.3:name>Stephanie Daignault-Newton</j.3:name><j.3:familyName>Daignault-Newton</j.3:familyName><j.3:givenName>Stephanie</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/walter-michael-stadler-1wh6jg4tnty1q"><j.3:name>Walter Michael Stadler</j.3:name><j.3:familyName>Stadler</j.3:familyName><j.3:givenName>Walter Michael</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/adam-jendrisak-1wh6jg4tnty1q"><j.3:name>Adam Jendrisak</j.3:name><j.3:familyName>Jendrisak</j.3:familyName><j.3:givenName>Adam</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><owl:sameAs rdf:resource="info:doi/10.1200/jco.2018.36.15_suppl.5012"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/felix-y-feng-1wh6jg4tnty1q"><j.3:name>Felix Y Feng</j.3:name><j.3:familyName>Feng</j.3:familyName><j.3:givenName>Felix Y</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:doi>10.1200/jco.2018.36.15_suppl.5012</j.2:doi><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2018-05-20</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/maha-hussain-1wh6jg4tnty1q"><j.3:name>Maha Hussain</j.3:name><j.3:familyName>Hussain</j.3:familyName><j.3:givenName>Maha</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>36</j.2:volume><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2018.36.15_suppl.5012"/><j.2:pageStart>5012</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jerry-lee-1wh6jg4tnty1q"><j.3:name>Jerry Lee</j.3:name><j.3:familyName>Lee</j.3:familyName><j.3:givenName>Jerry</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Phenotypic and genomic characterization of CTCs as a biomarker for prediction of Veliparib therapy benefit in mCRPC.</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ryan-dittamore-1wh6jg4tnty1q"><j.3:name>Ryan Dittamore</j.3:name><j.3:familyName>Dittamore</j.3:familyName><j.3:givenName>Ryan</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/yipeng-wang-1wh6jg4tnty1q"><j.3:name>Yipeng Wang</j.3:name><j.3:familyName>Wang</j.3:familyName><j.3:givenName>Yipeng</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/arul-chinnaiyan-1wh6jg4tnty1q"><j.3:name>Arul Chinnaiyan</j.3:name><j.3:familyName>Chinnaiyan</j.3:familyName><j.3:givenName>Arul</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>5012</j.2:pageEnd><owl:sameAs rdf:resource="doi:10.1200/jco.2018.36.15_suppl.5012"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ryon-p-graf-1wh6jg4tnty1q"><j.3:name>Ryon P Graf</j.3:name><j.3:familyName>Graf</j.3:familyName><j.3:givenName>Ryon P</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/angel-e-dago-1wh6jg4tnty1q"><j.3:name>Angel E Dago</j.3:name><j.3:familyName>Dago</j.3:familyName><j.3:givenName>Angel E</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>5012</j.1:startingPage><j.1:volume>36</j.1:volume><j.1:doi>10.1200/jco.2018.36.15_suppl.5012</j.1:doi><j.0:identifier>10.1200/jco.2018.36.15_suppl.5012</j.0:identifier><j.1:endingPage>5012</j.1:endingPage></rdf:Description></rdf:RDF>
